Edesa Biotech (EDSA) Other financing activities (2013 - 2023)
Edesa Biotech (EDSA) posted Other financing activities of $1.0 for Q3 2023, up 100.0% sequentially from -$12.0 million in Q3 2022, and up 100.0% YoY from $0.5 in Q3 2022.
Edesa Biotech (EDSA) Other financing activities (2013 - 2023) Analysis & Trends
Edesa Biotech has reported Other financing activities for 7 years, with the latest figure at $1.0 in Q3 2023.
- Quarterly Other financing activities rose 100.0% year-over-year to $1.0 in Q3 2023, while the trailing twelve-month figure through Sep 2024 was $1.0 (changed 0.0% YoY) and the FY2023 annual result came in at $770532.0, changed N/A from the prior year.
- Other financing activities rose to $1.0 in Q3 2023 per EDSA's latest filing, from -$12.0 million in the prior quarter.
- Over five years, Other financing activities peaked at $12.0 million in Q2 2022 and troughed at -$12.0 million in Q3 2022.
- A 4-year average of $697510.6 and a median of $472498.0 in 2021 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2023: Other financing activities sank 6352.88% in 2022, then jumped 100.0% in 2023.
- Over 4 years, Other financing activities stood at $995038.0 in 2020, then tumbled by 80.78% to $191233.0 in 2021, then tumbled by 6352.88% to -$12.0 million in 2022, then surged by 100.0% to $1.0 in 2023.
- According to Business Quant data, Other financing activities over the past three periods registered $1.0, -$12.0 million, and $12.0 million for Q3 2023, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Edesa Biotech | 40.44 Mn | 40.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.00 |
| Sep 30, 2023 | 1.00 |
| Sep 30, 2022 | -11.96 Mn |
| Sep 30, 2022 | -11.96 Mn |
| Jun 30, 2022 | 11.96 Mn |
| Jun 30, 2022 | 11.96 Mn |
| Sep 30, 2021 | 191,233.00 |
| Sep 30, 2021 | 191,233.00 |
| Mar 31, 2021 | 472,498.00 |
| Mar 31, 2021 | 472,498.00 |
| Dec 31, 2020 | 995,038.00 |
| Dec 31, 2020 | 995,038.00 |
| Sep 30, 2020 | 3.22 Mn |
| Sep 30, 2020 | 3.22 Mn |
| Dec 31, 2015 | 1.37 Mn |
| Dec 31, 2015 | 1.37 Mn |
| Sep 30, 2015 | 78,058.00 |
| Sep 30, 2015 | 78,058.00 |
| Dec 31, 2014 | 28,719.00 |
| Dec 31, 2014 | 28,719.00 |